Special Issue "Targeting Immune Checkpoints and Immunotherapy"
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (15 November 2017)
We are at the very beginning of a golden age in oncology. A major turning point in cancer immunotherapy came with the clinical application of antibodies that block immune checkpoints, including cytotoxic T lymphocyte–associated antigen 4 (CTLA-4) and the programmed cell death protein 1 pathway (PD-1/PD-L1). We envision more clinical studies coming forth and opening a new chapter on the treatment paradigm.
This Special Issue aims to update this important area. It is a platform for cancer investigators to update the most current clinical studies, investigational targets, and further mechanistic understanding of the therapy.
Original research and full review articles are welcomed to submit to this special issue.
Scope of the Special Issue as below but not exclusive:
- CAR T-cell immunotherapy for cancer
- Clinical trials on the cancer immunotherapy
- Immunotherapy, safety, side effects and drug resistance
- Combination of immunotherapy, radiotherapy and chemotherapy
- Neoantigen exposure and radiotherapy
- Detection assays for immune checkpoints
- Immuno-oncology treatment options
- Novel immune checkpoint targets for cancer immunotherapy
- Neoantigens signature
- Vaccines and vaccination
Dr. William Chi-shing Cho
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access bimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.